Income Statement

Revenue

+23%

+43%

10Y

Currency: KRW

	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	1 187	1 127	1 118	1 113	1 195	1 274	1 334	1 393	1 498	0	0	0	735	81	162	219	599	555	906	1 302	1 586	2 114	2 851	3 225	3 397	3 387	3 140	3 117	4 717	5 293	6 418	7 684	8 263	9 072	9 052	9 338	9 596	9 793	10 248	10 437	10 088	9 971	9 882	9 893	10 610	10 729	10 858	10 748	10 248	10 058	9 652	7 447	8 406	9 639	10 951	13 782	13 603	14 323	0	11 460	6 986	8 948	11 854	11 325
Revenue	338 166 N/A	348 122 +3%	373 414 +7%	382 031 +2%	400 443 +5%	423 567 +6%	441 506 +4%	470 305 +7%	484 346 +3%	173 229 -64%	347 843 +101%	525 099 +51%	669 014 +27%	659 087 -1%	644 236 -2%	639 939 -1%	682 508 +7%	690 275 +1%	714 185 +3%	734 716 +3%	735 889 +0%	758 475 +3%	778 975 +3%	812 337 +4%	839 686 +3%	857 252 +2%	869 025 +1%	862 689 -1%	883 920 +2%	898 632 +2%	927 951 +3%	959 672 +3%	960 307 +0%	973 799 +1%	990 152 +2%	995 896 +1%	1 031 427 +4%	1 055 676 +2%	1 086 724 +3%	1 098 179 +1%	1 113 426 +1%	1 107 157 -1%	1 068 432 -3%	1 075 830 +1%	1 055 424 -2%	1 067 635 +1%	1 103 386 +3%	1 117 201 +1%	1 152 976 +3%	1 181 714 +2%	1 214 081 +3%	1 255 325 +3%	1 280 092 +2%	1 304 151 +2%	1 332 284 +2%	1 341 290 +1%	1 375 329 +3%	1 388 699 +1%	1 399 052 +1%	1 416 626 +1%	1 422 683 +0%	1 443 386 +1%	1 488 291 +3%	1 541 649 +4%
Gross Profit
Cost of Revenue	(160 671)	(160 581)	(169 954)	(168 155)	(179 564)	(193 114)	(201 154)	(219 506)	(223 960)	(101 146)	(212 518)	(315 775)	(391 898)	(380 423)	(354 306)	(345 848)	(390 805)	(406 409)	(434 614)	(461 788)	(465 702)	(485 379)	(505 166)	(534 268)	(537 083)	(534 868)	(522 535)	(498 684)	(510 232)	(520 519)	(541 486)	(557 283)	(553 325)	(563 015)	(578 937)	(592 845)	(621 485)	(631 009)	(635 624)	(628 430)	(635 132)	(627 798)	(612 242)	(629 522)	(608 482)	(604 487)	(610 706)	(599 663)	(608 403)	(622 105)	(627 969)	(635 304)	(641 134)	(649 782)	(657 910)	(670 624)	(687 162)	(688 506)	(690 765)	(690 962)	(688 516)	(697 157)	(718 190)	(739 801)
Gross Profit	177 495 N/A	187 541 +6%	203 460 +8%	213 876 +5%	220 879 +3%	230 453 +4%	240 352 +4%	250 799 +4%	260 386 +4%	72 084 -72%	135 326 +88%	209 325 +55%	277 116 +32%	278 664 +1%	289 930 +4%	294 091 +1%	291 703 -1%	283 866 -3%	279 572 -2%	272 929 -2%	270 187 -1%	273 097 +1%	273 809 +0%	278 070 +2%	302 603 +9%	322 384 +7%	346 490 +7%	364 003 +5%	373 688 +3%	378 112 +1%	386 464 +2%	402 389 +4%	406 982 +1%	410 785 +1%	411 216 +0%	403 052 -2%	409 943 +2%	424 667 +4%	451 101 +6%	469 751 +4%	478 293 +2%	479 362 +0%	456 192 -5%	446 310 -2%	446 942 +0%	463 149 +4%	492 682 +6%	517 539 +5%	544 573 +5%	559 610 +3%	586 112 +5%	620 021 +6%	638 958 +3%	654 369 +2%	674 373 +3%	670 666 -1%	688 167 +3%	700 194 +2%	708 287 +1%	725 664 +2%	734 168 +1%	746 230 +2%	770 101 +3%	801 848 +4%
Operating Income
Operating Expenses	(126 389)	(130 841)	(134 869)	(138 055)	(150 594)	(161 783)	(172 544)	(182 834)	(186 986)	(61 051)	(124 160)	(183 395)	(240 233)	(236 574)	(226 396)	(222 786)	(220 331)	(214 401)	(213 994)	(217 029)	(218 243)	(223 614)	(225 605)	(233 939)	(259 039)	(287 553)	(322 275)	(345 896)	(347 794)	(350 722)	(354 844)	(360 668)	(368 026)	(374 753)	(375 314)	(373 512)	(385 377)	(407 935)	(419 128)	(438 767)	(433 606)	(441 735)	(444 539)	(434 948)	(429 962)	(429 180)	(436 785)	(444 849)	(455 844)	(470 216)	(485 388)	(511 911)	(543 160)	(557 146)	(567 127)	(564 137)	(565 575)	(572 415)	(578 251)	(587 733)	(586 225)	(589 252)	(597 580)	(609 711)
Selling, General & Administrative	(116 968)	(121 496)	(125 486)	(128 735)	(140 999)	(151 518)	(161 872)	(171 632)	(175 663)	(61 051)	(111 575)	(165 288)	(215 222)	(205 185)	(201 101)	(194 855)	(194 394)	(189 373)	(188 523)	(191 618)	(194 727)	(199 620)	(204 018)	(209 625)	(220 747)	(227 859)	(240 400)	(245 353)	(234 982)	(238 438)	(237 733)	(240 667)	(251 511)	(250 435)	(253 814)	(253 574)	(262 206)	(272 495)	(285 442)	(306 704)	(316 079)	(326 737)	(325 823)	(312 194)	(307 437)	(298 932)	(303 584)	(311 740)	(321 936)	(331 141)	(341 162)	(358 085)	(373 502)	(380 420)	(387 975)	(383 984)	(387 385)	(396 864)	(399 549)	(407 972)	(403 885)	(405 638)	(413 579)	(422 808)
Research & Development	(5 758)	(5 658)	(5 667)	(5 605)	(5 872)	(6 486)	(6 839)	(7 233)	(7 072)	0	0	(4 191)	(19 643)	(14 868)	(20 166)	(20 662)	(21 170)	(20 248)	(20 873)	(20 823)	(18 743)	(17 819)	(15 270)	(17 128)	(31 068)	(51 711)	(73 045)	(91 898)	(103 691)	(103 120)	(106 849)	(111 735)	(107 939)	(113 572)	(112 330)	(109 109)	(113 812)	(110 988)	(111 093)	(110 485)	(109 441)	(107 536)	(111 557)	(115 678)	(115 218)	(122 936)	(125 982)	(126 287)	(127 269)	(132 725)	(137 991)	(147 550)	(163 602)	(170 379)	(172 737)	(173 689)	(171 573)	(168 094)	(170 305)	(170 432)	(171 290)	(172 805)	(173 496)	(176 177)
Depreciation & Amortization	(3 663)	(3 687)	(3 716)	(3 715)	(3 723)	(3 779)	(3 833)	(3 969)	(4 251)	0	0	(1 332)	(5 368)	(3 938)	(5 130)	(4 978)	(4 768)	(4 610)	(4 599)	(4 589)	(4 774)	(5 090)	(5 231)	(6 369)	(7 224)	(7 982)	(8 828)	(8 643)	(9 121)	(9 164)	(9 026)	(8 268)	(8 576)	(8 353)	(9 170)	(10 830)	(9 359)	(9 345)	(8 550)	(7 533)	(8 087)	(7 464)	(7 160)	(7 077)	(7 307)	(7 312)	(7 219)	(6 822)	(6 638)	(6 350)	(6 236)	(6 276)	(6 057)	(6 348)	(6 415)	(6 465)	(6 616)	(7 457)	(8 397)	(9 329)	(11 051)	(10 808)	(10 505)	(10 725)
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	(12 585)	(12 584)	0	(12 583)	0	(2 291)	0	(170)	0	0	0	(1 085)	(1 086)	(817)	0	0	0	0	0	0	(1 236)	0	0	(2 393)	0	0	0	(15 107)	(14 043)	(14 045)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	51 106 N/A	56 698 +11%	68 589 +21%	75 819 +11%	70 285 -7%	68 670 -2%	67 808 -1%	67 967 +0%	73 400 +8%	11 033 -85%	11 166 +1%	25 930 +132%	36 883 +42%	42 090 +14%	63 535 +51%	71 306 +12%	71 372 +0%	69 467 -3%	65 578 -6%	55 900 -15%	51 944 -7%	49 483 -5%	48 205 -3%	44 132 -8%	43 564 -1%	34 832 -20%	24 216 -30%	18 109 -25%	25 894 +43%	27 390 +6%	31 620 +15%	41 720 +32%	38 957 -7%	36 031 -8%	35 901 0%	29 538 -18%	24 566 -17%	16 730 -32%	31 971 +91%	30 983 -3%	44 688 +44%	37 626 -16%	11 652 -69%	11 360 -3%	16 980 +49%	33 968 +100%	55 896 +65%	72 689 +30%	88 729 +22%	89 394 +1%	100 724 +13%	108 110 +7%	95 797 -11%	97 222 +1%	107 246 +10%	106 528 -1%	122 592 +15%	127 779 +4%	130 037 +2%	137 931 +6%	147 942 +7%	156 978 +6%	172 520 +10%	192 138 +11%
Pre-Tax Income
Interest Income Expense	3 267	3 803	3 590	4 766	3 697	4 185	1 859	6 177	3 307	3 298	7 081	1 623	427	(1 702)	(5 652)	586	2 233	103	173	78	2 028	2 417	1 998	1 653	896	(206)	(609)	(2 417)	(1 771)	(4 219)	(4 733)	(4 121)	(9 542)	(8 401)	(6 809)	(8 469)	(6 475)	(5 321)	(6 724)	(4 058)	(5 226)	(5 064)	(993)	(1 749)	8 124	10 372	5 006	4 377	7 923	(1 799)	(4 639)	(168)	(4 694)	(5 199)	(2 172)	(9 650)	(17 239)	(20 103)	(12 614)	(595)	(11 500)	(15 212)	(30 578)	(37 817)
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	(2 122)	(2 291)	0	(4 113)	0	0	(269)	(1 084)	0	0	0	(17)	(24)	(37)	(170)	(1 245)	(1 251)	0	(1 178)	(2 406)	0	(3 457)	(3 383)	(15 107)	0	0	0	(9 317)	0	0	0	(8 988)	0	0	0	(2 310)	0	0	0	(5 219)	0	0	0	29 464	0	0	0	(51 388)	0	0	0
Gain/Loss on Disposition of Assets	(2 419)	(2 554)	(2 700)	(3 001)	(3 181)	(153)	(450)	(734)	4	0	0	0	(131)	0	7	7	(102)	15	158	(43)	(75)	(80)	(242)	(168)	(764)	(813)	(699)	(497)	(81)	(35)	(138)	72	271	280	(890)	(1 170)	(9 238)	0	0	0	(17)	0	0	0	(720)	0	0	0	(1 029)	0	0	0	246	0	0	0	(1 221)	0	0	0	(466)	0	0	0
Total Other Income	(3 006)	(3 826)	(3 967)	(4 658)	(3 090)	(1 720)	576	1 186	2 864	1 287	2 062	2 555	4 546	3 378	3 575	3 887	4 613	4 498	4 472	968	873	1 170	1 098	4 711	4 072	3 777	4 590	5 359	4 813	4 464	8 689	8 051	8 853	9 759	5 882	6 429	5 632	(6 107)	(14 556)	(16 231)	(6 806)	(15 781)	(15 057)	(15 405)	(1 837)	(62 701)	(57 712)	(60 878)	(73 553)	(19 631)	(18 532)	(19 591)	(47 801)	(52 788)	(55 194)	(53 865)	(11 596)	4 240	(12 423)	(26 747)	(28 038)	(71 811)	(56 196)	(41 247)
Pre-Tax Income	48 948 N/A	54 121 +11%	65 513 +21%	72 927 +11%	67 711 -7%	70 982 +5%	69 793 -2%	74 595 +7%	79 575 +7%	15 617 -80%	20 308 +30%	30 108 +48%	41 725 +39%	41 646 0%	59 176 +42%	75 787 +28%	74 003 -2%	74 082 +0%	70 381 -5%	56 633 -20%	53 685 -5%	52 990 -1%	51 058 -4%	50 327 -1%	47 751 -5%	37 565 -21%	27 460 -27%	20 384 -26%	27 609 +35%	26 348 -5%	35 438 +34%	44 543 +26%	36 133 -19%	37 670 +4%	30 627 -19%	22 946 -25%	(623) N/A	5 302 N/A	10 691 +102%	10 694 +0%	23 322 +118%	16 781 -28%	(4 398) N/A	(5 794) -32%	13 559 N/A	(18 361) N/A	3 191 N/A	16 189 +407%	19 761 +22%	67 963 +244%	77 553 +14%	88 351 +14%	38 330 -57%	39 235 +2%	49 880 +27%	43 013 -14%	121 999 +184%	111 916 -8%	105 000 -6%	110 589 +5%	56 550 -49%	69 956 +24%	85 746 +23%	113 073 +32%
Net Income
Tax Provision	(13 712)	(15 523)	(18 290)	(20 428)	(19 188)	(19 831)	(19 838)	(21 118)	(20 749)	(4 328)	(4 411)	(7 808)	(8 212)	(7 824)	(13 103)	(16 261)	(16 028)	(15 786)	(14 383)	(26 455)	(23 215)	(23 376)	(23 405)	(9 130)	(12 078)	(9 792)	(7 372)	(5 038)	(1 483)	(1 521)	(4 465)	(5 871)	(696)	(1 164)	1 440	3 146	(14 795)	(15 987)	(17 145)	(16 300)	5 544	7 432	14 227	13 523	10 589	18 625	9 564	5 223	10 323	(3 742)	(6 055)	(7 620)	834	611	2 482	3 399	(1 996)	2 224	(20 934)	(13 508)	(33 204)	(34 747)	(9 097)	(17 381)
Income from Continuing Operations	35 236	38 598	47 224	52 500	48 523	51 152	49 955	53 477	58 826	11 289	15 897	22 300	33 513	33 822	46 073	59 526	57 974	58 297	55 999	30 179	30 470	29 613	27 651	41 196	35 674	27 773	20 089	15 346	26 126	24 827	30 973	38 672	35 436	36 507	32 068	26 094	(15 417)	(10 685)	(6 454)	(5 607)	28 866	24 214	9 829	7 728	24 148	261	12 753	21 412	30 084	64 221	71 498	80 731	39 163	39 846	52 362	46 412	120 003	114 141	84 066	97 081	23 347	35 209	76 648	95 692
Income to Minority Interest	0	0	0	0	0	0	0	0	122	163	268	335	566	724	665	610	425	511	701	997	1 075	942	925	3 462	7 256	6 640	5 932	4 357	844	2 605	3 480	645	(3 856)	(5 430)	(6 773)	(6 484)	265	(1 395)	140	(2 414)	(6 860)	(7 385)	(12 309)	(9 385)	(11 395)	(11 291)	(9 782)	(9 873)	(5 578)	(2 835)	1 233	1 532	3 076	4 184	(1 058)	(31)	1 736	334	6 807	6 492	1 388	3 276	(1 549)	(2 507)
Net Income (Common)	35 236 N/A	38 598 +10%	47 224 +22%	52 500 +11%	48 523 -8%	51 152 +5%	49 955 -2%	53 477 +7%	58 948 +10%	11 453 -81%	16 166 +41%	22 635 +40%	34 079 +51%	34 545 +1%	46 737 +35%	60 137 +29%	58 400 -3%	58 809 +1%	56 701 -4%	31 177 -45%	31 544 +1%	30 556 -3%	28 577 -6%	44 658 +56%	42 930 -4%	34 414 -20%	26 022 -24%	19 705 -24%	26 970 +37%	27 433 +2%	34 454 +26%	39 318 +14%	31 581 -20%	31 077 -2%	25 296 -19%	19 610 -22%	(15 152) N/A	(12 078) +20%	(6 313) +48%	(8 020) -27%	22 006 N/A	16 828 -24%	(2 481) N/A	(1 658) +33%	12 753 N/A	(11 030) N/A	2 971 N/A	11 539 +288%	24 506 +112%	61 386 +150%	72 731 +18%	82 263 +13%	42 240 -49%	44 030 +4%	51 305 +17%	46 381 -10%	121 739 +162%	114 474 -6%	90 872 -21%	103 573 +14%	24 735 -76%	38 484 +56%	75 100 +95%	93 185 +24%
EPS (Diluted)	3 203.27 N/A	3 508.9 +10%	4 293.09 +22%	4 772.72 +11%	4 411.18 -8%	4 650.18 +5%	4 541.36 -2%	4 861.54 +7%	5 358.9 +10%	1 145.3 -79%	1 616.6 +41%	2 263.5 +40%	3 407.9 +51%	3 454.5 +1%	4 673.7 +35%	6 013.7 +29%	5 840 -3%	5 880.9 +1%	5 670.1 -4%	3 117.7 -45%	3 154.4 +1%	3 055.6 -3%	2 857.7 -6%	4 465.8 +56%	4 293 -4%	3 441.4 -20%	2 602.19 -24%	1 970.5 -24%	2 697 +37%	2 743.3 +2%	3 445.4 +26%	3 931.8 +14%	3 158.1 -20%	3 107.7 -2%	2 529.6 -19%	1 961 -22%	-1 515.2 N/A	-1 207.8 +20%	-631.29 +48%	-802 -27%	2 200.6 N/A	1 682.8 -24%	-225.54 N/A	-150.72 +33%	1 159.36 N/A	-1 002.72 N/A	268.38 N/A	1 042.4 +288%	2 226.87 +114%	5 544.22 +149%	6 570.6 +19%	7 431.67 +13%	3 815.95 -49%	3 939.68 +3%	4 458.83 +13%	4 030.93 -10%	10 656.06 +164%	9 948.85 -7%	7 897.63 -21%	9 001.48 +14%	2 149.66 -76%	3 344.63 +56%	6 526.2 +95%	8 099.49 +24%

Income Statement Balance Sheet Cash Flow Statement

Daewoong Pharma
KRX:069620

Income Statement

Earnings Waterfall
Daewoong Pharma

Income Statement
Daewoong Pharma

See Also

Company

Help

Tools

Stocks

Daewoong Pharma KRX:069620

Income Statement

Earnings Waterfall Daewoong Pharma

Income Statement Daewoong Pharma

See Also

Company

Help

Tools

Stocks

Daewoong Pharma
KRX:069620

Earnings Waterfall
Daewoong Pharma

Income Statement
Daewoong Pharma